Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$50.3M |
| 2 |
CELG
Celgene Corp
CELG
|
+$40.9M |
| 3 |
PPLI
People Inc
PPLI
|
+$30.5M |
| 4 |
LPL Financial
LPLA
|
+$30M |
| 5 |
PayPal
PYPL
|
+$28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vistra
VST
|
+$36.3M |
| 2 |
TotalEnergies
TTE
|
+$30.7M |
| 3 |
VICI Properties
VICI
|
+$26.9M |
| 4 |
Intercontinental Exchange
ICE
|
+$22.6M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$17.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 18.33% |
| 2 | Healthcare | 13.73% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Technology | 10.72% |
| 5 | Communication Services | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Royal Caribbean
RCL
$78.1B
| $5.98M | 0.18% |
55,200
+40,700
| +281% | +$4.48M |
|
152
AstraZeneca
AZN
$257B
| $5.93M | 0.17% |
66,501
+53,451
| +410% | +$4.63M |
|
153
AbbVie
ABBV
$468B
| $5.85M | 0.17% |
77,300
-511
| -0.7% | -$35K |
|
154
United Therapeutics
UTHR
$22B
| $5.83M | 0.17% |
73,103
+60,503
| +480% | +$4.87M |
|
|
BPYU
155
DELISTED
Brookfield Property REIT Inc. Class A Common Stock
BPYU
| $5.8M | 0.17% |
284,657
+262,962
| +1,212% | +$5.08M |
|
156
Neurocrine Biosciences
NBIX
$15.5B
| $5.78M | 0.17% |
64,100
+26,200
| +69% | +$2.45M |
|
157
Lyft
LYFT
$6.61B
| $5.66M | 0.17% |
+138,533
| New | +$7.57M |
|
158
CVS Health
CVS
$119B
| $5.64M | 0.17% |
89,400
-238,200
| -73% | -$14.1M |
|
|
AAMI
159
Acadian Asset Management
AAMI
$3.28B
| $5.61M | 0.16% |
566,314
+396,199
| +233% | +$4.02M |
|
|
WMGI
160
DELISTED
Wright Medical Group Inc
WMGI
| $5.61M | 0.16% |
271,829
+223,429
| +462% | +$5.32M |
|
|
SAND
161
DELISTED
Sandstorm Gold
SAND
| $5.49M | 0.16% |
+974,000
| New | +$5.93M |
|
162
Allegiant Air
ALGT
$2.24B
| $5.45M | 0.16% |
+36,400
| New | +$5.33M |
|
163
Vertex Pharmaceuticals
VRTX
$139B
| $5.44M | 0.16% |
32,100
+15,500
| +93% | +$2.74M |
|
|
PARA
164
DELISTED
Paramount Global Class B
PARA
| $5.35M | 0.16% |
132,583
+126,583
| +2,110% | +$5.92M |
|
|
ALXN
165
DELISTED
Alexion Pharmaceuticals
ALXN
| $5.35M | 0.16% |
54,638
+45,960
| +530% | +$5.18M |
|
166
Genmab
GMAB
$20.6B
| $5.35M | 0.16% |
+264,045
| New | +$5.2M |
|
|
SMMCU
167
DELISTED
South Mountain Merger Corp. Unit
SMMCU
| $5.25M | 0.15% |
500,000
| – | – |
|
168
Energizer
ENR
$1.47B
| $5.23M | 0.15% |
+120,100
| New | +$4.78M |
|
|
FITB
169
Fifth Third Bancorp
FITB
$49.7B
| $5.23M | 0.15% |
191,000
-2,839
| -1% | -$77.8K |
|
170
Verizon
VZ
$205B
| $5.18M | 0.15% |
85,904
-9,302
| -10% | -$536K |
|
171
Rush Enterprises Class A
RUSHA
$8.54B
| $4.94M | 0.15% |
288,225
-234,848
| -45% | -$3.91M |
|
172
Sanofi
SNY
$110B
| $4.9M | 0.14% |
+105,700
| New | +$4.56M |
|
173
Jack Henry & Associates
JKHY
$11.8B
| $4.86M | 0.14% |
33,257
+24,775
| +292% | +$3.51M |
|
174
Target Hospitality
TH
$1.78B
| $4.85M | 0.14% |
712,305
-37,970
| -5% | -$287K |
|
175
Global Payments
GPN
$24.7B
| $4.85M | 0.14% |
30,500
+13,024
| +75% | +$2.13M |
|
Similar funds
Steve Schonfeld's Q3 2019 Portfolio in Review
As of Q3 2019, Steve Schonfeld held 1,378 positions worth $3.41B, up 20% from $2.83B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Steve Schonfeld deployed $847M of net new capital in Q3 2019, opening 421 new positions and adding to 275 existing holdings. Its largest new stake was Live Nation Entertainment: 265,765 shares worth $17.6M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Vistra, an estimated $36.3M trimmed.
- Steve Schonfeld's largest Q3 2019 buy was Live Nation Entertainment: 265,765 shares worth $17.6M.
- Steve Schonfeld added most to Equitrans Midstream Corporation Common Stock in Q3 2019, an estimated $50.3M increase.
- Steve Schonfeld's biggest Q3 2019 reduction was Vistra, cutting an estimated $36.3M.
- Steve Schonfeld fully exited TotalEnergies in Q3 2019, selling an estimated $30.7M.
- Steve Schonfeld's ten largest holdings make up 15% of its $3.41B portfolio in Q3 2019.
- Steve Schonfeld opened 421 new positions and closed 387 in Q3 2019.
- Steve Schonfeld's portfolio value rose 20% quarter-over-quarter to $3.41B.
Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.